Highlighting recommendations to ensure U.S. competitiveness, create high-paying jobs and find cures to costly and life-threatening diseases, this study reflects direct feedback of leaders and experts.
On December 14, the Council for American Medical Innovation and the New England Biotech Association held the "Best and Brightest Forum on Medical Innovation" in Providence, Rhode Island, featuring a panel discussion with state stakeholders and a keynote address from Patrick Kennedy.
Join the Council for a briefing series on Capitol Hill exploring how policies that promote medical innovation and a strong life sciences workforce can help our nation recover from both health and economic crises.
The Council for American Medical Innovation (CAMI), launched in 2009, has brought together leaders in research, medicine, public health, academia, education, labor, and business, who are working in partnership to encourage public policies that advance medical innovation and the development of lifesaving treatments, enhance job growth, and promote patient access.
Download the complete report here
Download the complete report and appendix here
WASHINGTON, D.C. (May 20, 2010) – “For more than a century, the United States has served as a shining example of what’s achievable through innovation, creativity and inventiveness," stated Debra Lappin, President of the Council for American Medical Innovation. "The IMD report out Wednesday illustrates the need to take a step back and carefully examine why, for the first time in decades, we’re falling behind other nations. With this data in hand, it’s time that we have a meaningful conversation on what needs to be done to reverse this alarming trend before it’s too late."
WASHINGTON, D.C. (February 24, 2010) – The Council for American Medical Innovation (CAMI) today applauded the Department of Health and Human Services, the Food and Drug Administration (FDA) and the National Institutes of Health (NIH) on the collaborative initiative to expedite the process for bringing medical innovations to the public marketplace.
“The leadership shown by Secretary Sebelius, Director Collins and Commissioner Hamburg in placing a priority on moving innovative therapies from the ‘microscope to the marketplace’ underscores the important and vital role that medical innovation plays in job creation and the health of our nation, our citizens and our economy,” said Debra R. Lappin, president of CAMI.
WASHINGTON, D.C. (January 28, 2010) “The Council for American Medical Innovation commends President Obama for his leadership in calling for a new agenda on job creation in America. As Congress responds, we must recognize that few areas hold greater promise for putting Americans back to work than our medical innovation enterprise.
Providence, RI (December 14, 2009) – Several of Rhode Island's most prominent leaders in research, medicine and biotechnology gathered today at Brown University's Medical Research Facility to discuss the importance of medical innovation in Rhode Island, and throughout the United States.
The forum highlighted the contributions of innovators in the state, and addressed the challenges facing the life sciences sector here.
WASHINGTON (December 11, 2009) As the U.S. Senate continues to debate health care reform, the Council for American Medical Innovation (CAMI) today applauded Sen. Arlen Specter for filing an amendment that would speed delivery of cures and treatments to patients in need. The Specter amendment would include key provisions of a revised Cures Acceleration Network (CAN) Act of 2009 within health care reform. Specifically, the legislation would establish a cutting edge Cures Acceleration Network within the Office of the Director of the National Institutes of Health (NIH).
JERSEY CITY, NJ (December 1, 2009) – Several of New Jersey’s most prominent leaders in biopharmaceuticals, research, medicine and technology gathered today at the Liberty Science Center to discuss the importance of medical innovation in New Jersey, and throughout the United States.
Participants in the forum called for new policies to support medical innovation, science and discovery in the state – suggesting that discoveries in the life sciences and medicine are critical to New Jersey’s economic recovery.
DES MOINES, IA (November 20, 2009) – Iowa leaders in biotechnology, health and medicine gathered in Des Moines today to discuss the importance of medical innovation and the opportunity to grow the Iowa economy. Panelists suggested that new discoveries in the life sciences and medicine are critical to the state’s future economic success.
Providence, Rhode Island (December 14, 2009) the Council for American Medical Innovation and New England Biotech Association co-hosted the Best & Brightest Forum on Medical Innovation at the Brown University medical research facility in Providence, Rhode Island. The event drew a crowd of nearly 100 medical innovation stakeholders, including representatives from government, industry, academia, research, education, patient groups, venture capital and the media.
Jersey City, New Jersey (December 1, 2009) the Council for American Medical Innovation, HealthCare Institute of New Jersey (HINJ), and We Work for Health New Jersey co-hosted the “Best and Brightest Forum on Medical Innovation” at the Liberty Science Center in Jersey City, NJ. The event featured remarks by HINJ President Bob Franks, Council Chairman Dick Gephardt, Congressman Frank Pallone (D-NJ), and closing comments by William Tansey, III, M.D., Chair of the Board of the Liberty Science Center.
© 2010 Council for American Medical Innovation. All rights reserved. About the Council | Contact Us | Privacy Policy
